Brief: VBI Vaccines Q3 Adjusted EPS USD -0.38
14/11/2023 21:05
Nov 14 (Reuters) - VBI Vaccines Q3 net income USD -20.444 million. * Q3 adjusted net income USD -8.012 million * Q3 operating expenses USD 16.693 million * Q3 operating income USD -10.069 million * Q3 revenue USD 6.624 million
Recent news on VBI Vaccines
See all newsBrief: VBI Vaccines Provides Update On Its Restructuring Proceedings
Brief: Vbi Vaccines Announces New Tumor Response Data From Ongoing Randomized Controlled Phase 2B Study Of Vbi-1901 In Recurrent Glioblastoma Patients
VBI Vaccines Inc reports results for the quarter ended in March - Earnings Summary
Brief: VBI Vaccines Says Entered At Market Offering Deal For Gross Proceeds Of Up To $8.5 Mln
Brief: VBI Vaccines Q1 Adjusted EPS USD -0.55